Cite

HARVARD Citation

    Lewis, J. et al. (2016). First experience of effectiveness and safety of bedaquiline for 18 months within an optimised regimen for XDR-TB. European respiratory journal. 47 (5), pp. 1581-1584. [Online]. 
  
Back to record